Skip to main content

Advertisement

Figure 5 | Journal of Neuroinflammation

Figure 5

From: Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [Nα-Bodipy]-des-Arg9-bradykinin

Figure 5

The ability of intraperitoneally injected [Nα-Bodipy]-des-Arg9-BK and its native agonist, des-Arg9-BK, to alter the paw withdrawal threshold in STZ-treated and control rats. Data represent maximal effects and are the average of 3 readings taken at 9, 12 and 15 min post-injection in 3 rats per group. Statistical comparison to control (*) and 2250 μg/kg des-Arg9-BK (+) are indicated by * + P < 0.05; ** P < 0.01; *** P < 0.001.

Back to article page